Patents Assigned to Ares Holding 89 N.V.
  • Treatment of neuropsychiatric disorders
    Patent number: 5468726
    Abstract: The administration of Somatostatin and growth hormone releasing factor at useful dosage levels alleviates the symptoms of various neuropsychiatric disorders.Growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor to mammals indicate its usefulness as an antemortem marker for senile dementia of the Alzheimer's type.
    Type: Grant
    Filed: February 23, 1990
    Date of Patent: November 21, 1995
    Assignee: Ares Holding 89 N.V.
    Inventor: Ramon Cacabelos